CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-08-13
DOI
10.3389/fphar.2020.01219
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Airway macrophages as the guardians of tissue repair in the lung
- (2019) Franz Puttur et al. IMMUNOLOGY AND CELL BIOLOGY
- Cystic Fibrosis Plasma Blunts the Immune Response to Bacterial Infection
- (2019) Xi Zhang et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- A Flow Cytometric Method for Isolating Cystic Fibrosis Airway Macrophages from Expectorated Sputum
- (2019) Katherine B. Hisert et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Cystic Fibrosis Inflammation: Hyper-inflammatory, Hypo-inflammatory, or Both?
- (2019) Sean V Murphy et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness
- (2019) Tao Sun et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Transcriptional consequences of impaired immune cell responses induced by cystic fibrosis plasma characterized via dual RNA sequencing
- (2019) Justin E. Ideozu et al. BMC Medical Genomics
- WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
- (2019) Yuxing Liao et al. NUCLEIC ACIDS RESEARCH
- Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis
- (2019) Benjamin T. Kopp et al. Journal of Cystic Fibrosis
- Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases
- (2019) Theodore S. Kapellos et al. Frontiers in Immunology
- New therapeutic strategies for IPF: Based on the “phagocytosis-secretion-immunization” network regulation mechanism of pulmonary macrophages
- (2019) Guoxiu Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Strong toll-like receptor responses in cystic fibrosis patients are associated with higher lung function
- (2019) Susanna Kosamo et al. Journal of Cystic Fibrosis
- Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity
- (2019) Scott D. Sagel et al. Journal of Cystic Fibrosis
- Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa
- (2018) Roxanna Barnaby et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Infection Is Not Required for Mucoinflammatory Lung Disease in CFTR-Knockout Ferrets
- (2018) Bradley H. Rosen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- CORK Study in Cystic Fibrosis
- (2018) Nicola J. Ronan et al. CHEST
- Macrophage Polarization as a Therapeutic Target in Myocardial Infarction
- (2018) Yuanyuan Cheng et al. CURRENT DRUG TARGETS
- Mutations of deubiquitinase OTUD1 are associated with autoimmune disorders
- (2018) Dan Lu et al. JOURNAL OF AUTOIMMUNITY
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function
- (2018) Shuzhong Zhang et al. Scientific Reports
- Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection
- (2017) Christina K. Lin et al. Journal of Innate Immunity
- mixOmics: An R package for ‘omics feature selection and multiple data integration
- (2017) Florian Rohart et al. PLoS Computational Biology
- Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations
- (2017) Ashutosh Sharma et al. PLoS One
- Characterisation of lung macrophage subpopulations in COPD patients and controls
- (2017) Jennifer A. Dewhurst et al. Scientific Reports
- Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency
- (2016) Claudio Sorio et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Ivacaftor-Induced Proteomic Changes Suggest Monocyte Defects May Contribute to the Pathogenesis of Cystic Fibrosis
- (2016) Katherine B. Hisert et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Long-term computed tomographic changes in cystic fibrosis patients treated with ivacaftor
- (2016) Guillaume Chassagnon et al. EUROPEAN RESPIRATORY JOURNAL
- Macrophages in Tissue Repair, Regeneration, and Fibrosis
- (2016) Thomas A. Wynn et al. IMMUNITY
- Alterations in blood leukocytes of G551D-bearing cystic fibrosis patients undergoing treatment with ivacaftor
- (2016) Preston E. Bratcher et al. Journal of Cystic Fibrosis
- Cystic Fibrosis Lung Immunity: The Role of the Macrophage
- (2016) Emanuela M. Bruscia et al. Journal of Innate Immunity
- Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients
- (2015) Valerie J. Waters et al. Journal of Cystic Fibrosis
- Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy
- (2015) André M. Cantin et al. Journal of Cystic Fibrosis
- ATF3 Is a Key Regulator of Macrophage IFN Responses
- (2015) Larisa I. Labzin et al. JOURNAL OF IMMUNOLOGY
- Free DNA in Cystic Fibrosis Airway Fluids Correlates with Airflow Obstruction
- (2015) Veronica Marcos et al. MEDIATORS OF INFLAMMATION
- The phosphatase DUSP2 controls the activity of the transcription activator STAT3 and regulates TH17 differentiation
- (2015) Dan Lu et al. NATURE IMMUNOLOGY
- Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis
- (2014) Steven M. Rowe et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor
- (2014) Sonya L. Heltshe et al. CLINICAL INFECTIOUS DISEASES
- A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis
- (2014) M.W. Konstan et al. Journal of Cystic Fibrosis
- Cystic Fibrosis Pulmonary Guidelines
- (2013) Peter J. Mogayzel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation
- (2013) K. De Filippo et al. BLOOD
- BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs
- (2013) Gerd Döring et al. Journal of Cystic Fibrosis
- Blood mRNA biomarkers for detection of treatment response in acute pulmonary exacerbations of cystic fibrosis
- (2013) J A Nick et al. THORAX
- Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation
- (2013) Alex R Horsley et al. THORAX
- Pulmonary Macrophage Subpopulations in the Induction and Resolution of Acute Lung Injury
- (2012) Laura K. Johnston et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Absence of the cystic fibrosis transmembrane regulator (Cftr ) from myeloid-derived cells slows resolution of inflammation and infection
- (2012) T. L. Bonfield et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Alternatively Activated Macrophages and Airway Disease
- (2011) Derek E. Byers et al. CHEST
- Small macrophages are present in early childhood respiratory disease
- (2011) Luke W. Garratt et al. Journal of Cystic Fibrosis
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Translocated LPS Might Cause Endotoxin Tolerance in Circulating Monocytes of Cystic Fibrosis Patients
- (2011) Rosa del Campo et al. PLoS One
- Soluble CD163
- (2011) Holger J. Møller SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Sputum and serum calprotectin are useful biomarkers during CF exacerbation
- (2010) R.D. Gray et al. Journal of Cystic Fibrosis
- Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis
- (2009) S. Brennan et al. EUROPEAN RESPIRATORY JOURNAL
- Pivotal Advance: Expansion of small sputum macrophages in CF: failure to express MARCO and mannose receptors
- (2009) Adam K. A. Wright et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Circulating RNA Transcripts Identify Therapeutic Response in Cystic Fibrosis Lung Disease
- (2008) Milene T. Saavedra et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Macrophages Directly Contribute to the Exaggerated Inflammatory Response in Cystic Fibrosis Transmembrane Conductance Regulator−/−Mice
- (2008) Emanuela M. Bruscia et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Monocyte chemoattractant chemokines in cystic fibrosis
- (2008) Satish Rao et al. Journal of Cystic Fibrosis
- Monocytes from Cystic Fibrosis Patients Are Locked in an LPS Tolerance State: Down-Regulation of TREM-1 as Putative Underlying Mechanism
- (2008) Carlos del Fresno et al. PLoS One
- ATF3 regulates MCMV infection in mice by modulating IFN- expression in natural killer cells
- (2008) C. M. Rosenberger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started